Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Loading
Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Calendar quarter Q2 2026Earnings call Jul 31, 2026 · most recent call
ABBV’s newest analyzed quarter is part of Tellvest Pro: its score, breakdown, narrative and analyst Q&A. Every prior quarter is free.
Sources. Scores: AbbVie’s public earnings-call transcripts and SEC-reported results — the base band is anchored to reported GAAP revenue growth; transcript, EPS and guidance adjustments are applied separately (documented exceptions apply to a few issuers). Price: ABBV daily closing prices for the trailing year; dots mark earnings calls, colored by that quarter’s score; the newest quarter’s score is part of Tellvest Pro. How to read a company earnings-call score.
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free. How to browse earnings-call scores without Pro. How to read a company earnings-call score.
The breakdown for this quarter is part of Tellvest Pro.
The table scrolls sideways. Swipe it, or select it and use the arrow keys.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $15.10B | +5.6% | $-0.02 | -103.9% | 70.9% | -9.9% | -0.1% | $6.76B |
| FY2025 Q1 | $13.34B | +8.4% | $0.72 | -6.5% | 70.0% | 28.0% | 9.6% | $1.40B |
| FY2025 Q2 | $15.42B | +6.6% | $0.53 | -31.2% | 71.8% | 31.7% | 6.1% | $4.88B |
| FY2025 Q3 | $15.78B | +9.1% | $0.10 | -88.7% | 66.4% | 12.1% | 1.2% | $7.53B |
| FY2025 Q4 | $16.62B | +10.0% | $1.02 | +5735.4% | 72.6% | 35.0% | 10.9% | $4.89B |
| FY2026 Q1 | $15.00B | +12.4% | $0.39 | -45.8% | 71.9% | 31.6% | 4.7% | $3.56B |
| FY2026 Q2Selected | $16.99B | +10.2% | $2.04 | +284.9% | 84.7% | 39.6% | 21.3% | — |
Management-stated figures from ABBV’s newest call are part of Tellvest Pro.
No 8-K events recorded since this call day.